Cognitive Behavioral Therapy for Insomnia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to improve Cognitive Behavioral Therapy for Insomnia (CBTi). Researchers aim to determine if modifications to CBTi can benefit individuals with chronic sleep issues, such as insomnia, which can impact brain health and memory. The trial will test various methods within CBTi, including adjustments to sleep habits and routines, to identify the most effective approach. Individuals with insomnia who are stable on non-sedating medications may be suitable candidates for this trial. As an unphased trial, it presents a unique opportunity to contribute to innovative research that could enhance sleep therapy for many.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must be stable on any prescribed, non-sedating medications for at least one month before participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBTi) is generally safe and well-tolerated. Studies have found that CBTi can improve sleep quality and offers long-term benefits compared to sleep medications, which often have side effects. Importantly, CBTi itself usually has no major side effects, though some people might feel a bit tired or less motivated.
The main parts of this therapy include:
1. **Sleep Compression**: This involves gradually spending less time in bed to improve sleep. It is as effective as sleep medication but without the side effects.
2. **Sleep Restriction**: This reduces the time spent awake in bed to enhance sleep. It works well, though initially, it might cause anxiety due to reduced sleep. This usually improves as sleep patterns stabilize.
3. **Stimulus Control**: This technique helps associate the bedroom only with sleep. It is effective, but initially, it might cause increased wakefulness at night until the body adjusts.
Overall, CBTi has shown promising results without the risks of medication. However, experiences can vary, and some people might feel a bit uncomfortable at first as they adjust to new sleep habits.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new approaches to treating insomnia with Cognitive Behavioral Therapy for Insomnia (CBTi). Unlike standard options like medication, which often work by targeting sleep chemicals in the brain, these CBTi techniques focus on changing behaviors and thoughts related to sleep. The Stimulus Control Core helps retrain the brain to associate the bedroom only with sleep, while the Sleep Restriction Core works to consolidate sleep by limiting time spent awake in bed. Meanwhile, the Sleep Compression Core gradually reduces time in bed over weeks to improve sleep quality. These methods offer a non-drug alternative that could reduce side effects and dependency associated with traditional sleep medications.
What evidence suggests that this trial's treatments could be effective for insomnia?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBTi) effectively treats insomnia. This trial will evaluate different components of CBTi, including stimulus control, sleep restriction, and sleep compression, each as separate treatment arms. Studies indicate that CBTi can reduce insomnia symptoms by half and improve both sleep quality and mental sharpness. Stimulus control therapy, one of the trial's arms, helps people fall asleep about 19 minutes faster and improves sleep quality. Sleep restriction therapy, another arm, enhances both sleep duration and quality. Sleep compression, the third arm, gradually reduces time spent in bed to make sleep more efficient, offering results similar to sleep medication but without side effects. Overall, CBTi is considered a safe, reliable, and effective treatment for those struggling with insomnia.12678
Who Is on the Research Team?
Sarah Emert
Principal Investigator
Idaho State University
Are You a Good Fit for This Trial?
This trial is for adults with insomnia disorder, aiming to improve their sleep and cognitive functioning. Participants should have a diagnosis of insomnia and be interested in non-medication therapy. Those currently on sedatives or with inconsistent treatment histories may not qualify.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Waitlist Control
Participants assigned to the waitlist control group will wait 4 weeks before starting treatment, maintaining their regular schedule
Treatment
Participants receive modified Cognitive Behavioral Therapy for Insomnia (CBTi) to improve sleep and cognitive function
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CBTi: Sleep Compression Core
- CBTi: Sleep Restriction Core
- CBTi: Stimulus Control Core
CBTi: Sleep Compression Core is already approved in United States, European Union, Canada for the following indications:
- Insomnia disorder
- Chronic insomnia
- Insomnia disorder
- Chronic insomnia
- Insomnia disorder
- Chronic insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Idaho State University
Lead Sponsor